- Home
- SABS vs PRTG Comparison
SABS vs PRTG Comparison
Compare SABS & PRTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SABS
- PRTG
- Stock Information
- Founded
- SABS 2014
- PRTG 1973
- Country
- SABS United States
- PRTG British Virgin Islands
- Employees
- SABS N/A
- PRTG N/A
- Industry
- SABS Biotechnology: Pharmaceutical Preparations
- PRTG Oil & Gas Production
- Sector
- SABS Health Care
- PRTG Energy
- Exchange
- SABS Nasdaq
- PRTG Nasdaq
- Market Cap
- SABS 15.8M
- PRTG 17.7M
- IPO Year
- SABS N/A
- PRTG N/A
- Fundamental
- Price
- SABS $1.76
- PRTG $5.29
- Analyst Decision
- SABS Strong Buy
- PRTG
- Analyst Count
- SABS 5
- PRTG 0
- Target Price
- SABS $11.80
- PRTG N/A
- AVG Volume (30 Days)
- SABS 33.1K
- PRTG 22.6K
- Earning Date
- SABS 08-07-2025
- PRTG 08-14-2025
- Dividend Yield
- SABS N/A
- PRTG N/A
- EPS Growth
- SABS N/A
- PRTG N/A
- EPS
- SABS N/A
- PRTG N/A
- Revenue
- SABS $377,835.00
- PRTG N/A
- Revenue This Year
- SABS N/A
- PRTG N/A
- Revenue Next Year
- SABS N/A
- PRTG N/A
- P/E Ratio
- SABS N/A
- PRTG N/A
- Revenue Growth
- SABS N/A
- PRTG N/A
- 52 Week Low
- SABS $1.00
- PRTG $2.10
- 52 Week High
- SABS $5.01
- PRTG $23.01
- Technical
- Relative Strength Index (RSI)
- SABS 47.99
- PRTG 29.84
- Support Level
- SABS $1.60
- PRTG $7.51
- Resistance Level
- SABS $1.80
- PRTG $8.17
- Average True Range (ATR)
- SABS 0.12
- PRTG 0.71
- MACD
- SABS -0.02
- PRTG -0.25
- Stochastic Oscillator
- SABS 50.00
- PRTG 1.39
About SABS SAB Biotherapeutics Inc.
SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.
About PRTG Portage Biotech Inc.
Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through clinical proof of concept with an initial focus on unmet clinical needs. It is an immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others.